1887

Journal of General Virology

Volume 98, Issue 12

Correction

Corrigendum: Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin

Marek Radkowski¹, Jolanta Opoka-Kegler², Kamila Caraballo Cortes¹, Iwona Bukowska-Ośko¹, Karol Perlejewski¹, Agnieszka Pawełczyk¹ and Tomasz Laskus¹
View Affiliations Hide Affiliations

¹ Department of Immunopathology, Warsaw Medical University, Warsaw, Poland ² Municipal Hospital for Infectious Diseases, Warsaw, Poland
*Correspondence: Tomasz Laskus, [email protected]
Published: 01 December 2017 https://doi.org/10.1099/jgv.0.000970

Preview this article:

There is no abstract available.

Received: 25/10/2017
Accepted: 25/10/2017
Published Online: 01/12/2017

Keyword(s): HCV , hepatitis C virus and ribavirin therapy

© 2017 The Authors

Erratum

This article contains a correction applying to the following content:

Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000970

2017-12-01

2025-05-21

Loading full text...

Full text loading...

/content/journal/jgv/10.1099/jgv.0.000970

Most cited Most Cited RSS feed

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error